JPRN-UMIN000004325已完成2 期
The efficacy and safety of Yokukansan for BPSD in Alzheimer's disease. a randomized, double-blind, placebo-control trial. - The efficacy and safety of Yokukansan for BPSD in Alzheimer's disease.
Institute of Development, Aging and Cancer Tohoku university, Department of Geriatrics and Gerontology0 个研究点目标入组 140 人开始时间: 2011年2月1日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 140
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 55years-old 至 84years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Patients with non-Alzheimer's dementia 2)No lesion exists in brain MRI. 3)Presence of severe illness 4)Those who have used Yokukansan ever before 5)Those who have joined any clinical trial within 3 month 6)Those who are thought inadequate by their doctor.
研究者
相似试验
未知
不适用
The safety and efficacy of Yokukansan in treating neuropsychiatric symptoms of patients with Fronto-Temporal Lobar Degeneration (FTLD)Fronto-Temporal Lobar Degeneration (FTLD)JPRN-UMIN000001897Ehime University Graduate School of Medicine20
招募中
2 期
Efficacy and safety of Yokukansan for the treatment-resistant schizophrenia: randomized, double-blind, placebo-controlled multicenter trialTreatment-Rsistant SchizophreniaJPRN-UMIN000005018Department of Psychiatry, Shimane University School of Medicine120
尚未招募
不适用
Cost effectiveness of Yokukansan for BPSD(behavioral and psychologicalsymptoms of dementia) in Mild to Moderate Alzheimer's disease and Dementia with Lewy bodies.Alzheimer&#39s disease and Dementia with Lewy bodies.JPRN-UMIN000020374Tokyo Women's Medical University100
招募中
不适用
Examination of efficacy of yokukansan for postoperative delirium.postoperative deliriumJPRN-UMIN000004417ippon Medical School Musashi Kosugi Hospital200
已完成
不适用
To investigate the efficacy and safety of Yokukansan for patients with insomniaPsychophysiological insomniaJPRN-UMIN000001412The Jikei university school of medicine10